554 related articles for article (PubMed ID: 1097148)
1. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
Hollister LE; Gillespie H
Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
[TBL] [Abstract][Full Text] [Related]
2. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
4. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
[TBL] [Abstract][Full Text] [Related]
5. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
Murphy LL; Steger RW; Smith MS; Bartke A
Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
Hiltunen AJ; Järbe TU
Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
[TBL] [Abstract][Full Text] [Related]
7. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.
Freeman AM; Petrilli K; Lees R; Hindocha C; Mokrysz C; Curran HV; Saunders R; Freeman TP
Neurosci Biobehav Rev; 2019 Dec; 107():696-712. PubMed ID: 31580839
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
10. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
Hiltunen AJ; Järbe TU; Kamkar MR; Archer T
Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367
[TBL] [Abstract][Full Text] [Related]
11. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Niesink RJ; Rigter S; Koeter MW; Brunt TM
Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
Colasanti BK; Brown RE; Craig CR
Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
14. Effects of marihuana in laboratory animals and in man.
Carlini EA; Karniol IG; Renault PF; Schuster CR
Br J Pharmacol; 1974 Feb; 50(2):299-309. PubMed ID: 4609532
[TBL] [Abstract][Full Text] [Related]
15. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
Järbe TU; Henriksson BG; Ohlin GC
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
[TBL] [Abstract][Full Text] [Related]
16. The effect of delta9-tetrahydrocannabinol, cannabidiol and cannabinol on ether anaesthesia in mice.
Malor R; Jackson DM; Chesher GB
J Pharm Pharmacol; 1975 Aug; 27(8):610-2. PubMed ID: 239179
[No Abstract] [Full Text] [Related]
17. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
Alozie SO; Martin BR; Harris LS; Dewey WL
Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
19. Absence of interaction between delta9-tetrahydrocannabinol (delta-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice.
Ham MT; De Jong Y
Psychopharmacologia; 1975; 41(2):169-74. PubMed ID: 1171491
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
Hine B; Torrelio M; Gershon S
Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
